Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kforce | KFRC | Jan 21, 2025 | 56.89 | +1.08 |
Kidpik | PIK | Jan 21, 2025 | 2.38 | 0.00 |
Kilroy Realty | KRC | Jan 21, 2025 | 39.19 | +0.59 |
Kimball Electronics | KE | Jan 21, 2025 | 19.51 | +1.77 |
Kimbell Royalty Partners LP Units | KRP | Jan 21, 2025 | 15.94 | -0.06 |
Kimberly-Clark | KMB | Jan 21, 2025 | 126.52 | -0.55 |
Kimco Realty | KIM | Jan 21, 2025 | 22.50 | +0.94 |
Kimco Realty L Pref | KIM-L | Jan 21, 2025 | 21.13 | +1.78 |
Kimco Realty M Pref | KIM-M | Jan 21, 2025 | 21.91 | +1.11 |
Kimco Realty Pref ADR | KIM-N | Jan 21, 2025 | 59.99 | 0.00 |
Kinder Morgan | KMI | Jan 21, 2025 | 31.22 | +3.00 |
Kindercare Learning Companies | KLC | Jan 21, 2025 | 21.25 | +5.72 |
Kindly MD | KDLY | Jan 21, 2025 | 1.44 | -2.13 |
Kinetik A | KNTK | Jan 21, 2025 | 66.47 | +1.99 |
Kingsoft Cloud ADR | KC | Jan 21, 2025 | 9.55 | -4.21 |
Kingstone Companies | KINS | Jan 21, 2025 | 15.99 | +4.03 |
Kingsway Financial Services | KFS | Jan 21, 2025 | 8.11 | -0.61 |
Kiniksa Pharmaceuticals | KNSA | Jan 21, 2025 | 18.71 | +0.92 |
Kinross Gold | KGC | Jan 21, 2025 | 10.64 | +3.20 |
Kinsale Capital Group | KNSL | Jan 21, 2025 | 439.15 | +0.64 |
Kiora Pharmaceuticals | KPRX | Jan 21, 2025 | 4.00 | +2.30 |
Kirby | KEX | Jan 21, 2025 | 112.81 | +0.78 |
Kirklands | KIRK | Jan 21, 2025 | 1.57 | 0.00 |
Kite Realty Group Trust | KRG | Jan 21, 2025 | 23.52 | +0.90 |
KKR & Co | KKR | Jan 21, 2025 | 160.71 | +1.99 |
KKR Income Opportunities Fund | KIO | Jan 21, 2025 | 13.12 | +0.77 |
KKR Real Estate Finance Trust | KREF | Jan 21, 2025 | 10.43 | -1.70 |
KKR Real Estate Finance Trust A Pref | KREF-A | Jan 21, 2025 | 19.82 | +0.32 |
KLA | KLAC | Jan 21, 2025 | 767.24 | +1.29 |
Klaviyo | KVYO | Jan 21, 2025 | 41.39 | +3.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.